
-
2002
Company Description
Xigen, a biopharmaceutical company, develops therapeutics to inhibit intracellular protein interactions.
Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland. Dr. Christophe Bonny, CEO and co-founder, is a renowned molecular biologist with over a decade's research expertise on intracellular peptides and signalling.
-
Manufacturer:
Science and Engineering -
Formed:
2002 -
Founders:
Christophe Bonny -
Company Website:
-
Company E-mail:
-
Company Address:
Route de la corniche 4EpalingesSwitzerland -
CEO:
- Christophe Bonny
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits